Skroot Laboratory, Inc. is a startup that operates in the biotechnology sector, specifically in the development of wireless process analytical technologies (PAT) for cell and protein therapy developers. In simpler terms, they create technologies that help streamline and improve the process of developing cell and protein therapies, which are treatments for diseases like cancer. The company's name, Skroot, is an anglicized form of the Polish word 'skrót,' meaning 'shortcut,' reflecting their mission to create faster and safer routes to these therapies.

Their primary clients are developers of cell and protein therapies, which can include pharmaceutical companies, research institutions, and other biotech firms. Skroot Lab operates in a highly specialized market, which is growing rapidly due to the increasing demand for more effective and personalized treatments.

Skroot Lab's business model is based on the development and sale of their proprietary technologies. They generate revenue through the licensing of these technologies to their clients. The company has also received significant funding from various sources, including the National Science Foundation (NSF), the CARES Act, the Iowa Economic Development Authority (IA EDA), and private angel investors, totaling over $1.6 million.

In summary, Skroot Lab is a promising startup in the biotech sector, with a focus on improving the development of cell and protein therapies. They have a strong funding background and operate in a rapidly growing market.

Keywords: Biotechnology, Cell Therapy, Protein Therapy, Technology Development, Pharmaceutical Industry, Research Institutions, Licensing, Funding, Startup, Process Analytical Technologies (PAT).